best glp 1 for dementia Can GLP-1s prevent Alzheimer's? NIH-funded UC study explores data - University of Cincinnati: Founder of Co-op, Leader in Co-op While some have noticed positive changes in their appetite and energy levels Blood Flow to Brain Function:

[4] Conditions that match a drugs FDA approval generally qualify, whether youre using these major GLP-1 brands or similar: Ozempic/Mounjaro: type 2 diabetes [5] Wegovy/Zepbound: obesity (BMI 30) [6] Wegovy/Zepbound: overweight with at least one weight-related condition (BMI 27 to under 30 plus hypertension, high cholesterol, sleep apnea, cardiovascular disease, or type 2 diabetes) [7] Zepbound: obstructive sleep apnea [8] Wegovy: metabolic-associated steatohepatitis (MASH) [9] Off-label conditions can count too when your clinician documents a real diagnosis such as prediabetes, binge eating disorder, or PCOS

b , Glucose tolerance test (GTT) and insulin during the GTT at 3 months of age (n = 6 Control and 5 NDI1)

In the Mayo Clinic study, women and people who also reported having constipation on the GLP-1 medications were more likely to receive a diagnosis of gastroparesis

Theyre not recommended if you have: Gastroparesis or severe GI conditions A personal or family history of medullary thyroid carcinoma or MEN2 genetic syndrome A history of pancreatitis Pregnancy or are breastfeeding Diabetic retinopathy (risk of worsening with rapid glucose drops) Always share your full health history with your providertransparency is critical for safe recommendations

MBM, Mind-body medicine